Yann Mazabraud
Corporate Officer/Principal bij RHYTHM PHARMACEUTICALS, INC.
Vermogen: 2 M $ op 31-03-2024
Profiel
Yann Mazabraud currently works at Rhythm Pharmaceuticals, Inc., as Executive Vice President & Head-International from 2020.
Mr. Mazabraud also formerly worked at Genzyme Corp., as General Manager-US & Head-North America from 2016 to 2017, Genzyme Therapeutics Ltd., as Head-Latin America, and Trevi Therapeutics, Inc., as Chief Commercial Officer & Head-International from 2017 to 2020.
Mr. Mazabraud received his graduate degree from Groupe de Sup de Co La Rochelle.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
15-04-2024 | 34 870 ( 0.06% ) | 2 M $ | 31-03-2024 |
Actieve functies van Yann Mazabraud
Bedrijven | Functie | Begin |
---|---|---|
RHYTHM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 05-10-2020 |
Eerdere bekende functies van Yann Mazabraud
Bedrijven | Functie | Einde |
---|---|---|
TREVI THERAPEUTICS, INC. | Corporate Officer/Principal | 03-10-2020 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-10-2017 |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Opleiding van Yann Mazabraud
Groupe de Sup de Co La Rochelle | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
RHYTHM PHARMACEUTICALS, INC. | Health Technology |
TREVI THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |